268 related articles for article (PubMed ID: 19621712)
41. Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension.
Anegawa G; Kawanaka H; Uehara H; Akahoshi T; Konishi K; Yoshida D; Kinjo N; Hashimoto N; Tomikawa M; Hashizume M; Maehara Y
J Gastroenterol Hepatol; 2009 Sep; 24(9):1554-8. PubMed ID: 19743999
[TBL] [Abstract][Full Text] [Related]
42. [Effects of alprostadil in prevention of portal vein thrombogenesis after splenectomy and devascularization: a clinical observation of 76 patients with portal hypertension].
Ma JC; Zhao J; Su QH; Zhang DH; Guo Y; Ji ZZ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):524-6. PubMed ID: 18649766
[TBL] [Abstract][Full Text] [Related]
43. Combined splenocaval or mesocaval C shunt and portoazygous devascularization in the treatment of portal hypertension: analysis of 150 cases.
Feng LS; Chen XP
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):70-3. PubMed ID: 16481287
[TBL] [Abstract][Full Text] [Related]
44. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: does increased hepatic arterial flow induce liver regeneration?
Liu Q; Ma K; Song Y; Zhou N; He Z
Surgery; 2008 Apr; 143(4):509-18. PubMed ID: 18374048
[TBL] [Abstract][Full Text] [Related]
45. Hepatic blood flow after acute biliary obstruction and drainage in conscious dogs.
Kanda H; Nimura Y; Yasui A; Uematsu T; Kamiya S; Machiki Y; Kitagawa Y; Shionoya S
Hepatogastroenterology; 1996; 43(7):235-40. PubMed ID: 8682470
[TBL] [Abstract][Full Text] [Related]
46. [Treating portal hypertension by subtotal splenectomy with retroperitoneal splenic transposition and devascularization: clinical study].
Li E; Zhao L; Zhu L; Lin A; Ge L; Wang F; Shi B
Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):333-5, 71. PubMed ID: 11825403
[TBL] [Abstract][Full Text] [Related]
47. Hepatic venous pressure gradient and outcomes in cirrhosis.
Ripoll C
J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
[TBL] [Abstract][Full Text] [Related]
48. [Pre- and postoperative splanchnic hemodynamics measured by indocyanine green clearance in patients with portal hypertension].
Song Y
Zhonghua Wai Ke Za Zhi; 1991 Nov; 29(11):669-72, 717. PubMed ID: 1818801
[TBL] [Abstract][Full Text] [Related]
49. [Indicators of hepatic and intracardiac hemodynamics in the surgical treatment of liver cirrhosis].
Khodzhibekov MKh; Akhmedzhanova ShSh; Miasnik BN; Nazyrov FG; Deviatov AV
Vestn Khir Im I I Grek; 1989 Jun; 142(6):25-8. PubMed ID: 2815467
[TBL] [Abstract][Full Text] [Related]
50. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
[TBL] [Abstract][Full Text] [Related]
51. [Magnetic resonance angiography in assessing changes of pre-and post-disconnective portal system in patients with portal hypertension].
Chen L; Yang L; Yang Z; Dai Z
Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):92-4. PubMed ID: 11831996
[TBL] [Abstract][Full Text] [Related]
52. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
[TBL] [Abstract][Full Text] [Related]
53. Postprandial changes in portal haemodynamics in patients with cirrhosis.
O'Brien S; Keogan M; Patchett S; McCormick PA; Afdhal N; Hegarty JE
Gut; 1992 Mar; 33(3):364-7. PubMed ID: 1568656
[TBL] [Abstract][Full Text] [Related]
54. A prospective experimental study of liver fibrosis with ultrasound and its correlation with hepatic reserve function and hemodynamics.
Yang YL; Di L; Duan YY; Liu X; Liu J; Yang RJ; Chen S; Yuan LJ
BMC Gastroenterol; 2012 Nov; 12():168. PubMed ID: 23173929
[TBL] [Abstract][Full Text] [Related]
55. Reconsideration of liver transplantation for portal hypertension due to hepatitis B cirrhosis: a single center experience.
Wang M; Li C; Yan LN; Wen TF; Li B; Zhang Y; Jiang L; Liang GL
Hepatogastroenterology; 2013 May; 60(123):496-500. PubMed ID: 23635447
[TBL] [Abstract][Full Text] [Related]
56. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
57. Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension.
Lu CL; Cao YJ; Cheng H; Pan YM; Bao SH; Xie M
Oncotarget; 2016 Aug; 7(31):50635-50642. PubMed ID: 27246983
[TBL] [Abstract][Full Text] [Related]
58. Prediction of posthepatectomy hepatic functional reserve by serum hyaluronate.
Yachida S; Wakabayashi H; Okano K; Suzuki Y
Br J Surg; 2009 May; 96(5):501-8. PubMed ID: 19358182
[TBL] [Abstract][Full Text] [Related]
59. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
[TBL] [Abstract][Full Text] [Related]
60. [Pre-and postoperative indocyanine green retention rate as a marker of liver functional reserve in cirrhotic patients].
Song Y
Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):102-5. PubMed ID: 8222999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
